Welltower (WELL) Stock Forecast & Price Target

Q: What analysts cover Welltower?

Welltower has been rated by research analysts at Barclays , BMO Capital Markets , BNP Paribas Exane , Cantor Fitzgerald , Citigroup , Evercore , Jefferies Financial Group , JPMorgan Chase & Co. , KeyCorp , Mizuho , Morgan Stanley , Robert W. Baird , Royal Bank Of Canada , Scotiabank , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$225.75 +2.71 (+1.21%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$225.42 -0.33 (-0.14%)

As of 10/9/2026 08:00 PM Eastern

Compare

Welltower - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 20 Analyst Ratings

Sell
0

Hold
3

Buy
17

Based on 20 Wall Street analysts who have issued ratings for Welltower in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 3 have given a hold rating, 15 have given a buy rating, and 2 have given a strong buy rating for WELL.

Consensus Price Target

$255.91
13.36% Upside

According to the 20 analysts' twelve-month price targets for Welltower, the average price target is $255.91. The highest price target for WELL is $277.00, while the lowest price target for WELL is $196.00. The average price target represents a forecasted upside of 13.36% from the current price of $225.75.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for WELL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Welltower and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

WELL Analyst Ratings Over Time

Type	Current Forecast 10/10/25 to 10/10/26	1 Month Ago 9/10/25 to 9/10/26	3 Months Ago 7/12/25 to 7/12/26	1 Year Ago 10/10/24 to 10/10/25
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	13 Buy rating(s)	11 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$255.91	$254.86	$239.40	$180.69
Forecasted Upside	13.36% Upside	7.97% Upside	3.49% Upside	8.96% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

WELL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WELL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Welltower Stock vs. The Competition

Type	Welltower	Real Estate Companies	Broader Market
Consensus Rating Score	2.95	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	13.36% Upside	58.56% Upside	19.63% Upside
News Sentiment Rating	Neutral News See Recent WELL News	Positive News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/8/2026	Weiss Ratings 3 of 5 stars		Upgrade	Hold (C+) ➝ Buy (B-)
9/25/2026	Jefferies Financial Group 3 of 5 stars	Joe Dickstein Not Rated	Upgrade	Strong-Buy
9/24/2026	JPMorgan Chase & Co. 3 of 5 stars	Michael Mueller 3 of 5 stars	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $260.00	+13.11%
9/21/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Kammert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$260.00 ➝ $256.00	+9.68%
9/2/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$244.00 ➝ $251.00	+5.06%
9/1/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Kamdem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$215.00 ➝ $251.00	+5.96%
9/1/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kilichowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$237.00 ➝ $266.00	+12.29%
8/31/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$254.00 ➝ $259.00	+9.05%
8/12/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$226.00 ➝ $233.00	+0.94%
8/4/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Wurschmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$240.00 ➝ $275.00	+17.90%
Get the Latest News and Ratings for WELL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Welltower and its competitors with MarketBeat's FREE daily newsletter.
8/3/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$238.00 ➝ $260.00	+10.61%
8/3/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$245.00 ➝ $265.00	+14.80%
7/31/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$235.00 ➝ $260.00	+11.29%
7/31/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$255.00 ➝ $275.00	+16.74%
7/28/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$238.00 ➝ $272.00	+17.83%
7/22/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$239.00 ➝ $260.00	+6.08%
7/8/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$249.00 ➝ $271.00	+14.11%
7/1/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omotayo Okusanya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$215.00 ➝ $265.00	+14.90%
6/16/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Rodgers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Strong-Buy ➝ Outperform	$226.00	+5.70%
5/26/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target		$260.00 ➝ $277.00	+19.93%
12/1/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$162.00 ➝ $252.00	+9.02%
10/29/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Viacheslav Obodnikov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$196.00	+11.45%
10/17/2025	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$246.00	+41.02%
4/17/2025	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	R. Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Underperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:15 AM ET.

Should I Buy Welltower Stock? WELL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Welltower pros and cons to contact@marketbeat.com.

Welltower
Bull Case

Here are some ways that investors could benefit from investing in Welltower Inc.:

Welltower Inc. has received a wave of positive analyst sentiment recently, with Jefferies Financial Group upgrading the stock to a strong-buy rating and JPMorgan raising its rating to overweight with a price target of $260. This consensus of optimism is reflected in the current stock price of $223.22, which is significantly below the consensus price target of $255.39, suggesting substantial upside potential for investors who align with the bullish outlook of major financial institutions.
The company is benefiting from favorable demographic trends, as approximately two million Americans are expected to turn 80 this year while senior housing construction remains historically low. This supply-demand imbalance supports the long-term growth of Welltower Inc.'s core business in senior housing and post-acute care, potentially leading to higher occupancy rates and stable rental income for shareholders.
Welltower Inc. demonstrated strong revenue growth in its most recent reported quarter, with revenue increasing by 39.1% year-over-year to $3.54 billion. This significant expansion in top-line revenue indicates that the company is successfully scaling its operations and capturing market share in the healthcare real estate sector, which is a key driver for long-term value creation.
Institutional investors continue to show confidence in the company, with major funds such as BlackRock Inc. and State Street Corp increasing their holdings in Welltower Inc. during the second quarter. BlackRock raised its stake by 5.5%, and State Street boosted its position by 1.4%, signaling that large-scale investors view the company as a stable and attractive addition to their portfolios.
Insider activity suggests confidence in the company's future performance, as Director Andrew Gundlach purchased 5,000 shares of Welltower Inc. stock in late August 2026. This transaction, valued at approximately $1.21 million, represents a 20% increase in his personal position, indicating that company leadership believes the stock is undervalued or poised for further growth.

Welltower
Bear Case

Investors should be bearish about investing in Welltower Inc. for these reasons:

Welltower Inc. recently missed its earnings per share expectations, reporting $0.61 in EPS for the quarter compared to the consensus estimate of $0.66. This miss, despite strong revenue growth, raises concerns about the company's ability to convert top-line growth into bottom-line profitability, which could pressure the stock if future results continue to underwhelm.
The stock is trading at a high valuation multiple, with a price-to-earnings ratio of 102.39. This elevated P/E ratio means that investors are paying a premium for Welltower Inc.'s earnings, which leaves little room for error. Any deceleration in growth or disappointment in guidance could lead to a significant correction in the stock price, as noted by analysts who argue the shares are priced for continued compounding that may be slowing.
Short interest in Welltower Inc. has been relatively high, with approximately 17.6 million shares shorted as of the most recent record date. This level of short interest, representing about 2.45% of the float, indicates that a portion of the market is betting against the stock, which could create downward pressure on the price if negative news emerges or if short sellers continue to add to their positions.
Welltower Inc. has a high debt-to-equity ratio of 0.37, which, while manageable, still represents a significant level of leverage. In a rising interest rate environment, higher debt levels can increase financing costs and reduce the company's financial flexibility, potentially impacting its ability to invest in new properties or maintain its dividend payout.
The company's dividend yield of 1.51% is relatively low compared to other real estate investment trusts, which may make it less attractive to income-focused investors. While the stock has strong growth potential, the modest dividend yield means that investors are relying heavily on capital appreciation rather than regular income, which could be a drawback for those seeking a steady cash flow from their investments.

WELL Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Welltower is $255.91, with a high forecast of $277.00 and a low forecast of $196.00.

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Welltower in the last year. There are currently 3 hold ratings, 15 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" WELL shares.

According to analysts, Welltower's stock has a predicted upside of 13.36% based on their 12-month stock forecasts.

Over the previous 90 days, Welltower's stock had 3 upgrades by analysts.

Welltower has been rated by research analysts at Barclays, BMO Capital Markets, BNP Paribas Exane, Cantor Fitzgerald, Citigroup, Evercore, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank Of Canada, Scotiabank, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Welltower more than other "real estate" companies. The consensus rating for Welltower is Moderate Buy while the average consensus rating for "real estate" companies is Hold. Learn more on how WELL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Welltower Recommendations

MarketBeat monitors more than a dozen sources for Welltower analyst ratings, with the most recent rating issued on 10/8/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Welltower (WELL) Stock Forecast & Price Target